Cor Vasa 2008, 50(2):55-59 | DOI: 10.33678/cor.2008.027

Reperfusion therapy in ST-segment elevation myocardial infarction - data from a pilot registry of myocardial infarction

Zdeněk Monhart1,*, Václav Faltus2,3, Hana Grünfeldová3,4, Alena Kadlečková3, Dana Ryšavá5, Tomáš Velimský6, Lubomír Ballek7, Ján Hubač8, Petr Janský9, Jana Zvárová2
1 Interní oddělení, Nemocnice Znojmo
2 Centrum biomedicínckých informací, Praha
3 Ústav počítačových věd AV ČR, v. v. i., Praha
4 Interní oddělení, Nemocnice Čáslav
5 Interní oddělení, Nemocnice Kutná Hora
6 Interní oddělení, Nemocnice Písek
7 Interní oddělení, Nemocnice Jindřichův Hradec
8 Interní oddělení, Nemocnice Chrudim
9 Kardiovaskulární centrum, Fakultní nemocnice Motol, Praha, Česká republika

Aim:
To assess utilization of primary reperfusion therapy in patients with acute phase of ST-segment elevation myocardial infarction (STEMI) in the Czech Republic.

Methods:
A total of 744 consecutive patients with STEMI from years 2003-2006 were included in the study. Also, data on their demographics and reperfusion strategy were collected. An assessed clinical outcome was in-hospital mortality.

Results:
The mean age of STEMI patients was 66.9 ± 12.6 years. The vast majority were men (62.4%). A total of 68.6% STEMI patients received primary reperfusion treatment, 97.0% of them were referred for PPCI and 3.6% were treated with fibrinolytic therapy. Women and elderly patients were less likely to receive reperfusion therapy. The in-hospital mortality was 11.3% for all STEMI patients; 3.5% and 25.7% in the reperfused and non-reperfused groups, (p < 0.001). When adjusting for age, the effect of reperfusion therapy remained significant.

Conclusions:
In-hospital mortality was significantly reduced in a subgroup of patients who underwent primary reperfusion treatment (PPCI or fibrinolytic therapy). The PPCI represents the entirely prevalent form of reperfusion strategy in the Czech Republic.

Keywords: Myocardial infarction; Reperfusion therapy; Mortality

Published: February 1, 2008  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Monhart Z, Faltus V, Grünfeldová H, Kadlečková A, Ryšavá D, Velimský T, et al.. Reperfusion therapy in ST-segment elevation myocardial infarction - data from a pilot registry of myocardial infarction. Cor Vasa. 2008;50(2):55-59. doi: 10.33678/cor.2008.027.
Download citation

References

  1. Van de Werf F, Ardissino D, Betriu A, et al. Management of acute myocardial infarction in patients presenting with ST-segment elevation. The Task Force on the Management of Acute Myocardial Infarction of the European Society of Cardiology. Eur Heart J 2003; 24:28-66. Go to original source... Go to PubMed...
  2. Antman EM, Anbe DT, Armstrong PW, et al. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction; A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1999 Guidelines for the Management of patients with acute myocardial infarction). J Am Coll Cardiol 2004; 44:E1-E211. Go to original source... Go to PubMed...
  3. Widimsky P, Janousek S, Vojacek J. Guidelines for the management of ST-elevation myocardial infarction. Cor Vasa 2002;44:K123-K143.
  4. Maggioni AP, Franzosi MG, Fresco C, et al. GISSI trials in acute myocardial infarction. Rationale, design, and results. Chest 1990;97(4 Suppl):146S-150S. Go to original source... Go to PubMed...
  5. Widimský P, Groch L, Zelízko M, et al. Multicentre randomized trial comparing transport to primary angioplasty vs immediate thrombolysis vs combined strategy for patients with acute myocardial infarction presenting to a community hospital without a catheterization laboratory. The PRAGUE study. Eur Heart J 2000;21: 823-31. Go to original source... Go to PubMed...
  6. Peterson ED, Roe MT, Mulgund J, et al. Association between hospital process performance and outcomes among patients with acute coronary syndromes. JAMA 2006;295:1912-20. Go to original source... Go to PubMed...
  7. Hasdai D, Behar S, Wallentin L, et al. A prospective survey of the characteristics, treatments and outcomes of patients with acute coronary syndromes in Europe and the Meditterean basin. The Euro Heart Survey of Acute Coronary Syndromes. Eur Heart J 2002;23:1190-201. Go to original source... Go to PubMed...
  8. Mandelzweig L, Battler A, Boyko V, et al. The second Euro Heart Survey on acute coronary syndromes: Characteristics, treatment, and outcome of patients with ACS in Europe and the Mediterranean Basin in 2004. Eur Heart J. 2006;27:2285-93. Go to original source... Go to PubMed...
  9. Di Chiara A, Chiarella F, Savonitto S, et al. Epidemiology of acute myocardial infarction in the Italian CCU network: the BLITZ study. Eur Heart J 2003;24:1616-29. Go to original source... Go to PubMed...
  10. Birkhead JS, Weston C, Lowe D. Impact of specialty of admitting physician and type of hospital on care and outcome for myocardial infarction in England and Wales during 2004-5: observational study. Br Med J 2006;332:1306-11. Go to original source... Go to PubMed...
  11. Kalla K, Christ G, Karnik R, et al. Implementation of guidelines improves the standard of care: the Viennese registry on reperfusion strategies in ST-elevation myocardial infarction (Vienna STEMI registry). Circulation 2006;113:2398-405. Go to original source... Go to PubMed...
  12. Tousek F, Jelinek P, Vacha M, et al. Treatment of ST-elevation myocardial infarction in the heart of Europe: analysis of the South Bohemian Coronary Registry. Interv Akut Kardiol 2004;3:181-4.
  13. Widimsky P, Zelizko M, Jansky P, Tousek F, Holm F, Aschermann M; CZECH investigators. The incidence, treatment strategies and outcomes of acute coronary syndromes in the "reperfusion network" of different hospital types in the Czech Republic: results of the Czech evaluation of acute coronary syndromes in hospitalized patients (CZECH) registry. Int J Cardiol 2007;119:212-9. Go to original source... Go to PubMed...
  14. Cohen M, Gensini GF, Maritz F, et al. Prospective evaluation of clinical outcomes after acute ST-elevation myocardial infarction in patients who are ineligible for reperfusion therapy: preliminary results from the TETAMI registry and randomized trial. Circulation 2003;108 (16 Suppl 1):III14-III21. Go to original source... Go to PubMed...
  15. Terkelsen CJ, Lassen JF, Nørgaard BL, et al. Mortality rates in patients with ST-elevation vs. non-ST-elevation acute myocardial infarction: observations from an unselected cohort. Eur Heart J 2005;26:18-26. Go to original source... Go to PubMed...
  16. Di Pede F, Olivari Z, Schievano E, et al. Impact of reperfusion strategies on in-hospital outcome in ST-elevation myocardial infarction in a context of interhospital network: data from the prospective VENERE registry (VENEto acute myocardial infarction REgistry. Ital Heart J Suppl 2005;6:804-11.




Cor et Vasa

You are accessing a site intended for medical professionals, not the lay public. The site may also contain information that is intended only for persons authorized to prescribe and dispense medicinal products for human use.

I therefore confirm that I am a healthcare professional under Act 40/1995 Coll. as amended by later regulations and that I have read the definition of a healthcare professional.